Federated Hermes, Inc. Applied Molecular Transport Inc. Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.24 - $0.37 $50 - $77	-210 Reduced 9.9%	1,911 $0
Q4 2022 Feb 13, 2023	BUY	$0.35 - $1.26 $236 - $853	677 Added 46.88%	2,121 $0
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $1,617 - $4,505	1,444 New	1,444 $1,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.